Notably, treatment with IPA led to an increased infiltration of CD8+ T cells into the tumor microenvironment, thereby enhancing the responsiveness to ICB treatment, which was not observed in Rag1-deficient mice (the mice lack mature B and T cells). The gene discussed is CD8A; the disease is neoplasm.